Anna Yordanova

2.2k total citations
39 papers, 1.6k citations indexed

About

Anna Yordanova is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Anna Yordanova has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Radiology, Nuclear Medicine and Imaging, 19 papers in Pulmonary and Respiratory Medicine and 16 papers in Oncology. Recurrent topics in Anna Yordanova's work include Radiopharmaceutical Chemistry and Applications (22 papers), Prostate Cancer Treatment and Research (17 papers) and Neuroendocrine Tumor Research Advances (12 papers). Anna Yordanova is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (22 papers), Prostate Cancer Treatment and Research (17 papers) and Neuroendocrine Tumor Research Advances (12 papers). Anna Yordanova collaborates with scholars based in Germany, Bulgaria and Iran. Anna Yordanova's co-authors include Hojjat Ahmadzadehfar, Markus Essler, Elisabeth Eppard, Stefan Kürpig, Rolf Fimmers, Georg Feldmann, Stefan Hauser, Kambiz Rahbar, Carl Diedrich Schlenkhoff and Florian Gaertner and has published in prestigious journals such as Clinical Cancer Research, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Anna Yordanova

39 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Yordanova Germany	19	1.2k	1.1k	676	276	171	39	1.6k
Sue Ping Thang Singapore	9	1.2k 1.0×	1.3k 1.1×	566 0.8×	219 0.8×	105 0.6×	28	1.7k
Germo Gericke United States	4	1.0k 0.8×	1.2k 1.0×	563 0.8×	168 0.6×	66 0.4×	6	1.6k
Meltem Ocak Türkiye	22	922 0.7×	781 0.7×	482 0.7×	387 1.4×	155 0.9×	54	1.5k
Madhav Prasad Yadav India	22	1.1k 0.9×	677 0.6×	963 1.4×	371 1.3×	170 1.0×	59	1.8k
Aviral Singh Germany	27	1.4k 1.1×	1.1k 0.9×	1.2k 1.8×	788 2.9×	457 2.7×	62	2.3k
Chandler H. Park United States	8	1.1k 0.9×	1.2k 1.0×	602 0.9×	127 0.5×	34 0.2×	20	1.7k
Justin Ferdinandus Germany	18	1.5k 1.2×	1.5k 1.3×	1.0k 1.5×	156 0.6×	34 0.2×	51	2.3k
Filippo Lodi Italy	21	844 0.7×	780 0.7×	246 0.4×	113 0.4×	66 0.4×	46	1.4k
Seval Beykan Germany	9	627 0.5×	507 0.4×	327 0.5×	126 0.5×	70 0.4×	13	843
Uta Eberlein Germany	17	789 0.6×	451 0.4×	246 0.4×	164 0.6×	68 0.4×	48	1.0k

Countries citing papers authored by Anna Yordanova

Since Specialization

Citations

This map shows the geographic impact of Anna Yordanova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Yordanova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Yordanova more than expected).

Fields of papers citing papers by Anna Yordanova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Yordanova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Yordanova. The network helps show where Anna Yordanova may publish in the future.

Co-authorship network of co-authors of Anna Yordanova

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Yordanova. A scholar is included among the top collaborators of Anna Yordanova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Yordanova. Anna Yordanova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yordanova, Anna, et al.. (2023). Elevated serum levels of TNF-α and IL-17 in psoriatic and rheumatoid arthritis. 31(1). 23–36. 1 indexed citations

Yordanova, Anna, et al.. (2022). APPROACH AND INDICATOR SYSTEM FOR ASSESSMENT THE IMPACTS OF RESERVOIRS AND PROLONGED DROUGHT IDENTIFICATION IN BULGARIA FOR WATER FRAMEWORK DIRECTIVE. International Multidisciplinary Scientific GeoConference SGEM .... 22. 57–64. 1 indexed citations

Yordanova, Anna, et al.. (2022). ANALYSIS OF HYDROLOGICAL DROUGHT INDICES AND THEIR RELATIONSHIP WITH METEOROLOGICAL FACTORS AND RIVER BASIN SPECIFICS. International Multidisciplinary Scientific GeoConference SGEM .... 22. 41–48. 1 indexed citations

Todorova, Nadezhda, et al.. (2021). Anti-Idiotype scFv Localizes an Autoepitope in the Globular Domain of C1q. International Journal of Molecular Sciences. 22(15). 8288–8288. 2 indexed citations

Assadi, Majid, Narges Jokar, Anna Yordanova, et al.. (2021). Emerging Preclinical and Clinical Applications of Theranostics for Nononcological Disorders. PET Clinics. 16(3). 429–440. 1 indexed citations

Eppard, Elisabeth, et al.. (2021). An Impressive Approach in Nuclear Medicine. PET Clinics. 16(3). 327–340. 18 indexed citations

Ahmadzadehfar, Hojjat, Richard P. Baum, Robert Seifert, et al.. (2021). The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [177Lu]Lu-PSMA-617: a WARMTH multicentre study. European Journal of Nuclear Medicine and Molecular Imaging. 48(12). 4067–4076. 29 indexed citations

Yordanova, Anna, Hans‐Jürgen Biersack, & Hojjat Ahmadzadehfar. (2020). Advances in Molecular Imaging and Radionuclide Therapy of Neuroendocrine Tumors. Journal of Clinical Medicine. 9(11). 3679–3679. 8 indexed citations

Yordanova, Anna, Karin Mayer, Peter Brossart, et al.. (2018). The Role of Adding Somatostatin Analogues to Peptide Receptor Radionuclide Therapy as a Combination and Maintenance Therapy. Clinical Cancer Research. 24(19). 4672–4679. 58 indexed citations

10.

Yordanova, Anna, Stefan Hauser, Michael Meisenheimer, et al.. (2018). Outcome and safety of rechallenge [177Lu]Lu-PSMA-617 in patients with metastatic prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 46(5). 1073–1080. 64 indexed citations

11.

Yordanova, Anna, Elisabeth Eppard, Stefan Kürpig, et al.. (2017). Theranostics in nuclear medicine practice. OncoTargets and Therapy. Volume 10. 4821–4828. 158 indexed citations

12.

Ahmadzadehfar, Hojjat, Simone Wegen, Anna Yordanova, et al.. (2017). Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617. European Journal of Nuclear Medicine and Molecular Imaging. 44(9). 1448–1454. 129 indexed citations

13.

Rahbar, Kambiz, Martin Boegemann, Anna Yordanova, et al.. (2017). PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival. European Journal of Nuclear Medicine and Molecular Imaging. 45(1). 12–19. 122 indexed citations

14.

Rahbar, Kambiz, Anna Yordanova, Maria Eveslage, et al.. (2017). Delayed response after repeated 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 45(2). 243–246. 58 indexed citations

15.

Yordanova, Anna, Karin Mayer, Peter Brossart, et al.. (2017). Safety of multiple repeated cycles of 177Lu-octreotate in patients with recurrent neuroendocrine tumour. European Journal of Nuclear Medicine and Molecular Imaging. 44(7). 1207–1214. 57 indexed citations

16.

Rahbar, Kambiz, Matthias Schmidt, Alexander Heinzel, et al.. (2016). Response and tolerability after a single dose of Lu-177-PSMA-617 in patients with metastatic castration resistant prostate cancer: a multicenter Study. Kölner Universitäts PublikationsServer (Universität zu Köln). 1 indexed citations

17.

Ahmadzadehfar, Hojjat, Stefan Hauser, Xiao X. Wei, et al.. (2016). ⁶⁸Ga-PSMA-11 PET as a Gatekeeper for the Treatment of Metastatic Prostate Cancer with ²²³Ra: Proof of Concept. Journal of Nuclear Medicine. 58(3). 438–444. 41 indexed citations

18.

Yordanova, Anna, Karin Mayer, Markus Essler, & Hojjat Ahmadzadehfar. (2016). Successful Repeated Peptide Receptor Radionuclide Therapies in Renal Neuroendocrine Tumor With Osseous Metastasis. Clinical Nuclear Medicine. 41(12). 977–979. 5 indexed citations

19.

Ferdinandus, Justin, Elisabeth Eppard, Florian Gaertner, et al.. (2016). Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with ¹⁷⁷Lu-PSMA-617. Journal of Nuclear Medicine. 58(2). 312–319. 101 indexed citations

20.

Rahbar, Kambiz, Matthias Schmidt, Alexander Heinzel, et al.. (2016). Response and Tolerability of a Single Dose of¹⁷⁷Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Analysis. Journal of Nuclear Medicine. 57(9). 1334–1338. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact